Bone morphogenetic protein 10 as predictor for adverse outcomes in patients with atrial fibrillation

Back

ESC Professional Premium Access

Bone morphogenetic protein 10 as predictor for adverse outcomes in patients with atrial fibrillation

Session: Epidemiological aspects of atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor E. Hennings (Basel, CH)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Elisa Hennings

University Hospital Basel, Basel (Switzerland)

0 follower

5 more presentations in this session

Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010.

Speaker: Professor L. Fauchier (Tours, FR)

Access

Abstract

Slides

Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: Data from PREVEND

Speaker: Mr A. Al Mubarak (Groningen, NL)

Access

Abstract

Slides

Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry

Speaker: Doctor G. Romiti (Rome, IT)

Access

Abstract

Slides

Prediction of incident atrial fibrillation with GDF-15 and echocardiographic left atrial volumes: data from the Akershus cardiac examination 1950 study

Speaker: Doctor P. Roenningen (Baerum, NO)

Access

Abstract

Slides

Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry

Speaker: Doctor W. Ding (Liverpool, GB)

Access

Abstract

Slides

Access the full session

Epidemiological aspects of atrial fibrillation

Speakers: Doctor E. Hennings, Professor L. Fauchier, Mr A. Al Mubarak, Doctor G. Romiti, Doctor P. Roenningen...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources